Sacro Cuore Don Calabria General Hospital Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2017
NCT03134729
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

IRCCS Sacro Cuore Don Calabria di Negrar | IRCCS Sacro Cuore Don Calabria hospital